Asia Pacific Newborn Screening Market Size & Outlook
Asia Pacific newborn screening market, 2018-2030 (US$M)
Related Markets
Asia Pacific newborn screening market highlights
- The Asia Pacific newborn screening market generated a revenue of USD 264.0 million in 2023.
- The market is expected to grow at a CAGR of 8% from 2024 to 2030.
- In terms of segment, tandem mass spectrometry was the largest revenue generating technology in 2023.
- Electrophoresis is the most lucrative technology segment registering the fastest growth during the forecast period.
- Country-wise, India is expected to register the highest CAGR from 2024 to 2030.
Asia Pacific data book summary
| Market revenue in 2023 | USD 264.0 million |
| Market revenue in 2030 | USD 451.1 million |
| Growth rate | 8% (CAGR from 2023 to 2030) |
| Largest segment | Tandem mass spectrometry |
| Fastest growing segment | Electrophoresis |
| Historical data covered | 2018 - 2022 |
| Base year for estimation | 2023 |
| Forecast period covered | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Tandem Mass Spectrometry, Pulse Oximetry, Enzyme-based Assay, DNA Assays, Electrophoresis |
| Key market players worldwide | Bio-Rad Laboratories Inc, Agilent Technologies, Agilent Technologies Inc, Covidien, Masimo Corp, Waters Corp, Natus Medical, GE HealthCare Technologies Inc Common Stock, PerkinElmer, Danaher Corp |
Other key industry trends
- In terms of revenue, Asia Pacific region accounted for 33.1% of the global newborn screening market in 2023.
- Globally, Asia Pacific is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 451.1 million by 2030.
Tandem mass spectrometry was the largest segment with a revenue share of 24.66% in 2023. Horizon Databook has segmented the Asia Pacific newborn screening market based on tandem mass spectrometry, pulse oximetry, enzyme-based assay, dna assays, electrophoresis covering the revenue growth of each sub-segment from 2018 to 2030.
Owing to the high population density, higher birth rate, and soaring prevalence of the congenital diseases, Asia Pacific is expected to be the fastest growing market for newborn screening techniques. Developing economies in countries such as India, China, Australia, and New Zealand are expected to favor the penetration of the market in this region.
Presently, there are more developing programs compared to developed programs in the region. Supportive government initiatives to increase awareness for the same are expected to result in lucrative growth over the forecast period.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Newborn Screening Market Scope
Newborn Screening Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Asia Pacific newborn screening market size, by country, 2018-2030 (US$M)
Asia Pacific Newborn Screening Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
